Both starting pitching and the bullpen can be fingered for most of the Rangers' 2H issues, and these are two areas that will again be the primary focal points for the front office this winter. That SPs Max Scherzer and Nathan Eovaldi remain under contract through 2024 is obviously good news for the Rangers. But Scherzer turns 40 next season, and his bottom-line performance, skills (3.91 / 4.03 ERA/xERA) and health are already suspect. Eovaldi has been superb (2.90 / 3.72 ERA/xERA) when whole, but he's missed six weeks in the 2H with a forearm strain—and at age 34 with a poor health history, more injury timeouts are likely. Both Jon Gray and Dane Dunning project to return as back-of-the-rotation arms, though both have...
Almost!
You’re just a few clicks away from accessing this feature and hundreds more throughout the year that have a singular goal in mind: Winning your league. Subscribe to BaseballHQ.com here!
Already a subscriber? Sign in here